Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DOCS Doximity, Inc.

Pre-Mkt 01-12 08:38:49 EST

43.79

+0.05

+0.11%

盘前43.62

-0.17-0.39%

08:30 EST

High45.17	Low43.51	Vol2.56M
Open44.70	D1 Closing43.74	Amplitude3.80%
Mkt Cap8.24B	Tradable Cap5.83B	Total Shares188.27M
T/O112.75M	T/O Rate1.93%	Tradable Shares133.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DOCS","market":"US","secType":"STK","nameCN":"Doximity, Inc.","latestPrice":43.79,"timestamp":1767992400000,"preClose":43.74,"halted":0,"volume":2563009,"hourTrading":{"tag":"盘前","latestPrice":43.62,"preClose":43.79,"latestTime":"08:30 EST","volume":322,"amount":14094.248476,"timestamp":1768224650653},"delay":0,"floatShares":133129121,"shares":188271269,"eps":1.248726,"marketStatus":"Pre-Mkt","change":0.05,"latestTime":"01-12 08:38:49 EST","open":44.7,"high":45.17,"low":43.51,"amount":112750974.370778,"amplitude":0.037952,"askPrice":43.7,"askSize":41,"bidPrice":43.44,"bidSize":130,"shortable":3,"etf":0,"ttmEps":1.248726,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768228200000},"marketStatusCode":1,"adr":0,"listingDate":1624507200000,"exchange":"NYSE","adjPreClose":43.79,"preHourTrading":{"tag":"盘前","latestPrice":43.62,"preClose":43.79,"latestTime":"08:30 EST","volume":322,"amount":14094.248476,"timestamp":1768224650653},"postHourTrading":{"tag":"盘后","latestPrice":43.79,"preClose":43.79,"latestTime":"19:59 EST","volume":76256,"amount":3339286.2825,"timestamp":1768006771570},"volumeRatio":0.8181590318113612,"impliedVol":0.7715,"impliedVolPercentile":0.696},"requestUrl":"/m/hq/s/DOCS/tweets","defaultTab":"tweets","newsList":[{"id":"2602370365","title":"Doximity's Double-Digit Growth Rate is Sustainable, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2602370365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602370365?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:04","pubTimestamp":1767974648,"startTime":"0","endTime":"0","summary":"Doximity's  double-digit growth rate is sustainable through higher penetration of health care professional marketing, RBC Capital Markets said in a Thursday note, as it initiated coverage on the stock.The firm said that Doximity is one of the \"highest quality\" health care technology stocks in the sector with double-digit growth and margins of over 50%.RBC said that while pharma marketing budgets are under pressure, allocation to health care professional marketing is expected to offset this pressure.RBC said that increased allocation by Mega brands to health care professional marketing can yield net revenue retention of 113% due to renewals and upsells.The firm said that concerns surrounding regulatory headwinds and scrutiny from the US Food and Drug Administration into direct-to-consumer marketing are \"overdone\".RBC has an outperform rating on the stock and a $59 price target.Price: 43.81, Change: +0.06, Percent Change: +0.15","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DOCS","BK4551","BK4613","BK4167","BK4585","BK4588","BK4539"],"gpt_icon":0},{"id":"2602783153","title":"Doximity Inc : Truist Securities Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2602783153","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602783153?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:57","pubTimestamp":1767959834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA11Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4167","DOCS","BK4613","BK4539","BK4588","BK4551"],"gpt_icon":0},{"id":"2602140320","title":"RBC Initiates Doximity at Outperform With $59 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2602140320","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602140320?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:39","pubTimestamp":1767958784,"startTime":"0","endTime":"0","summary":"Doximity (DOCS) has an average rating of overweight and mean price target of $64.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DOCS"],"gpt_icon":0},{"id":"2602313137","title":"Doximity initiated with an Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313137?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:30","pubTimestamp":1767907859,"startTime":"0","endTime":"0","summary":"RBC Capital initiated coverage of Doximity (DOCS) with an Outperform rating and $59 price target Published first on TheFly – the ultimate source fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/doximity-initiated-with-an-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/doximity-initiated-with-an-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2602020392","title":"Partner sees spending on Doximity growing at faster rate, Raymond James says","url":"https://stock-news.laohu8.com/highlight/detail?id=2602020392","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602020392?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:55","pubTimestamp":1767898512,"startTime":"0","endTime":"0","summary":"Raymond James analyst Brian Peterson says the firm hosted a webinar with a marketing agency partner that oversees $100M-$150M in annual spending fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/partner-sees-spending-on-doximity-growing-at-faster-rate-raymond-james-says-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/partner-sees-spending-on-doximity-growing-at-faster-rate-raymond-james-says-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2265009873.SGD","BK4167","BK4613","LU1363072403.SGD","BK4585","RJF","DOCS","BK4551","BK4127","LU0971096721.USD","BK4539","BK4588","IE00B64PRP62.GBP","LU1804176565.USD"],"gpt_icon":0},{"id":"2601039844","title":"Doximity upgraded to Buy from Hold at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2601039844","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601039844?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:31","pubTimestamp":1767882682,"startTime":"0","endTime":"0","summary":"Truist analyst Jailendra Singh upgraded Doximity (DOCS) to Buy from Hold with a $62 price target Doximity continues to gain market share and outper...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/doximity-upgraded-to-buy-from-hold-at-truist-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/doximity-upgraded-to-buy-from-hold-at-truist-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DOCS"],"gpt_icon":0},{"id":"2601229360","title":"Doximity Is Maintained at Overweight by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2601229360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601229360?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:22","pubTimestamp":1767882120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DOCS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 09:22 ET (14:22 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOCS"],"gpt_icon":0},{"id":"2601368213","title":"Is Insurance-Funded Securities Settlement Reshaping Doximity’s AI Growth Narrative (DOCS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601368213","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601368213?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:42","pubTimestamp":1767822160,"startTime":"0","endTime":"0","summary":"In December 2025, Doximity agreed to a US$31 million, insurance-funded settlement to resolve a federal securities lawsuit, with all claims against the company and its executives dismissed without any admission of wrongdoing, pending court and shareholder approvals.\nAt the same time, Doximity’s strong quarterly revenue growth and new AI tools for clinicians highlight how its core business momentum continues alongside legal resolution efforts.\nWith the securities lawsuit settlement set to be...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-insurance-funded-securities-settlement-reshaping-doximity","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-insurance-funded-securities-settlement-reshaping-doximity","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","AI","BK4551","BK4528","BK4588","BK4613","BK4587","BK4543","BK4023","DOCS","BK4585","BK4167"],"gpt_icon":0},{"id":"2601848270","title":"Doximity Director Kira Scherer Wampler Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601848270","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601848270?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:02","pubTimestamp":1767733349,"startTime":"0","endTime":"0","summary":"Kira Scherer Wampler, Director at Doximity Inc., has reported a disposal of common shares of Doximity Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL7Rh68P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Doximity Director Kira Scherer Wampler Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BK4588","BK4551","BK4613","BK4167","DOCS"],"gpt_icon":0},{"id":"2601656278","title":"Assessing Doximity (DOCS) Valuation After Securities Litigation Settlement Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2601656278","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601656278?lang=en_us&edition=fundamental","pubTime":"2026-01-06 10:22","pubTimestamp":1767666146,"startTime":"0","endTime":"0","summary":"Doximity (DOCS) has reached a proposed settlement to resolve its securities litigation, with a US$31 million payment expected to be fully covered by insurance, subject to court and stockholder approvals.\nSee our latest analysis for Doximity.\nThe settlement news lands after a weaker patch for the stock, with a 30 day share price return of 5.75% and a 90 day share price return of 39.35%. The 1 year total shareholder return is 22.10% and the 3 year total shareholder return is 41.24%. This...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/assessing-doximity-docs-valuation-after-securities-litigatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/assessing-doximity-docs-valuation-after-securities-litigatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","AI","BK4551","BK4613","BK4588","DOCS","BK4585","BK4167"],"gpt_icon":0},{"id":"2601835932","title":"Doximity Seen As 'Coiled Spring' Awaiting Positive Catalyst -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601835932?lang=en_us&edition=fundamental","pubTime":"2026-01-06 00:56","pubTimestamp":1767632160,"startTime":"0","endTime":"0","summary":"11:56 ET - Doximity's underperformance in stock price since October is a sign of substantial upside potential, Morgan Stanley analysts write in a note. \"We view DOCS as a coiled spring for a material move higher on any positive developments,\" they write, naming the health technology firm as a top battleground stock for 2026. There's been negative sentiment from investors around an apparent deceleration in growth in the fiscal third quarter and the threat of losing market share to OpenEvidence. But the analysts see space for both companies to succeed, and advise against overlooking solid growth on a full-year basis, suggesting strong business fundamentals. \"This is the best setup we've seen on the long side in a couple of years,\" they write. Shares are up 3.2% to $44.68.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU1074936037.SGD","BK4539","IE00BKVL7J92.USD","LU0267386448.USD","LU1989772840.SGD","LU0158827781.USD","LU2347655156.SGD","BK4127","BK4534","LU0320765646.SGD","LU0106261372.USD","LU1162221912.USD","LU0098860793.USD","LU2357305700.SGD","LU0528227936.USD","BK4588","LU2028103732.USD","BK4613","LU1548497426.USD","LU1720051108.HKD","LU0106831901.USD","LU1668664300.SGD","LU1244550577.SGD","LU1244550494.USD","LU1720051017.SGD","LU2089283258.USD","LU0557290698.USD","LU0158827948.USD","LU2089284900.SGD","LU2133065610.SGD","LU1732799900.SGD","LU0006306889.USD","DOCS","LU1791710582.SGD","LU0795875086.SGD","BK4585","LU0314104364.USD","BK4504","LU1244550221.USD","LU0225283273.USD","LU0882574139.USD","BK4581","LU0912757837.SGD","LU1989772923.USD","LU1363072403.SGD","LU0971096721.USD","LU1791710400.SGD","LU2023251221.USD","BK4167"],"gpt_icon":0},{"id":"2595717149","title":"Doximity Inc - on December 24, Enters Into $31 Mln Settlement Agreement to Resolve Securities Litigation- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717149?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:08","pubTimestamp":1767128923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4613","BK4539","BK4167","DOCS","BK4551","BK4585"],"gpt_icon":0},{"id":"2595717147","title":"Doximity Inc - Settlement Payment of $31 Mln Fully Funded by Insurance Proceeds - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717147?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:08","pubTimestamp":1767128923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00HQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","BK4167","BK4588","BK4539","BK4551","BK4585","DOCS"],"gpt_icon":0},{"id":"2595717916","title":"Doximity Reaches $31 Million Settlement in Securities Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717916","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717916?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:01","pubTimestamp":1767128517,"startTime":"0","endTime":"0","summary":"Doximity Inc. and certain company directors and officers have been named as defendants in a securities litigation case pending in the United States District Court for the Northern District of California, titled In re Doximity, Inc. Securities Litigation, No. 5:24-cv-02281. On December 24, 2025, the parties reached an agreement to settle the lawsuit for $31 million, with the entire amount to be covered by insurance. The settlement, which does not involve any admission of liability or wrongdoing, is subject to court approval and other customary conditions. If approved, all claims against Doximity and the named individuals will be dismissed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL49PzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4613","DOCS","BK4167","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"2595734036","title":"Doximity Engagement Gains Drive Revenues Higher -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2595734036","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595734036?lang=en_us&edition=fundamental","pubTime":"2025-12-30 01:33","pubTimestamp":1767029580,"startTime":"0","endTime":"0","summary":"1233 ET - Doximity should see engagement ramping for the foreseeable future, providing a durable revenue growth driver over time, Raymond James analysts say in a note after meeting with the company's CEO. The company offers a much more compelling suite of AI productivity tools than its competitors, which largely offer point solutions, and also said recently it will offer peer review functionality to its clinical decision-making tools, the analysts say. Those offerings should drive further adoption of the company's products, they say. \"We believe AI will provide a material increase in engagement for Doximity, where we believe the company has an underappreciated competitive moat,\" they say, backing their strong buy rating on the stock. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Doximity Engagement Gains Drive Revenues Higher -- Market Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOCS"],"gpt_icon":0},{"id":"2594997232","title":"What Doximity (DOCS)'s PeerCheck AI Review Launch and Analyst Support Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2594997232","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594997232?lang=en_us&edition=fundamental","pubTime":"2025-12-25 19:23","pubTimestamp":1766661830,"startTime":"0","endTime":"0","summary":"Earlier in December, Bank of America analyst Allen Lutz reiterated a positive rating on Doximity, highlighting growing healthcare provider budgets, increased advertising to these customers, and the launch of PeerCheck, a physician-led framework for clinical review of medical AI tools.\nThe combination of renewed analyst confidence and Doximity’s push into physician-supervised AI validation underscores how the platform is trying to embed itself more deeply into clinicians’ daily digital...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/what-doximity-docss-peercheck-ai-review-launch-and-analyst-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/what-doximity-docss-peercheck-ai-review-launch-and-analyst-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","BK4167","BK4613","AI","BK4528","DOCS","BK4585","BK4588","BK4543","BK4539","BK4587","BK4023"],"gpt_icon":0},{"id":"2591266696","title":"BUZZ-Doximity rises after Morgan Stanley upgrades to 'overweight'","url":"https://stock-news.laohu8.com/highlight/detail?id=2591266696","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591266696?lang=en_us&edition=fundamental","pubTime":"2025-12-16 02:35","pubTimestamp":1765823745,"startTime":"0","endTime":"0","summary":"BUZZ-Doximity rises after Morgan Stanley upgrades to 'overweight'** Shares of telehealth company Doximity DOCS.N up 3.5% at $45.37** Morgan Stanley upgrades to \"overweight\" from \"equal-weight\" rating; raises PT to $65 from $62** Brokerage says stricter constraints on direct-to-consumer drug advertising could drive pharma companies to spend more on platforms for healthcare professionals like Doximity, representing potential upside to its estimates** Sees an expanding market for healthcare professionals, helped by AI-enabled workflow tools and believes concerns over competitive risks from OpenEvidence are overdone** Also adds DOCS has consistently expanded a suite of tools, deepening its integration into clinicians’ daily workflows, resulting in increased engagement and higher monetization** 13 of 22 brokerages rate the stock \"buy\" or higher, 7 \"hold\", 2 \"sell\"; their median PT is $65 — data compiled by LSEG** As of last close, stock down ~18% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DOCS","BK4588","BK4551","BK4539","BK4167","BK4613"],"gpt_icon":0},{"id":"2591628081","title":"Doximity Offers Attractive Entry Point, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628081?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:30","pubTimestamp":1765816220,"startTime":"0","endTime":"0","summary":"Doximity's (DOCS) recent stock correction provides an attractive entry point amid higher engagement and monetization of its  platform tools, Morgan Stanley said in a Monday report.\"Underperformance in","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0528227936.USD","LU1732800096.USD","LU1791710582.SGD","LU0006306889.USD","LU0267386448.USD","MS","BK4534","LU1989772923.USD","LU2357305700.SGD","IE00BKVL7J92.USD","LU0795875086.SGD","LU1244550494.USD","LU0320765646.SGD","LU2347655156.SGD","LU0158827781.USD","DOCS","LU0912757837.SGD","LU1720051108.HKD","LU1548497426.USD","BK4516","LU0106261372.USD","LU1244550221.USD","LU2271345857.HKD","LU0795875169.SGD","BK4581","LU0098860793.USD","BK4551","BK4127","LU1244550577.SGD","LU1363072403.SGD","LU1720051017.SGD","LU0158827948.USD","LU2111349929.HKD","LU1732799900.SGD","LU2089283258.USD","BK4504","LU1162221912.USD","LU0971096721.USD","LU0882574139.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","LU2089284900.SGD","BK4167","LU0557290698.USD","LU1989772840.SGD","BK4585","LU0106831901.USD","LU1791710400.SGD","BK4588","LU1074936037.SGD"],"gpt_icon":0},{"id":"2591641558","title":"the Hershey Company : Morgan Stanley  Raises to Overweight From Equal-Weight","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641558?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:26","pubTimestamp":1765805212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0MJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","BK4613","LU0170899867.USD","BK4551","DOCS","HSY","BK4588","BK4539","BK4585","BK4212","BK4504","BK4532","BK4533"],"gpt_icon":0},{"id":"2591641539","title":"Doximity, Inc. : Morgan Stanley  Raises Target Price to $65.00 From $62.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641539?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:26","pubTimestamp":1765805212,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0MJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","BK4504","BK4585","BK4212","DOCS","LU0170899867.USD","BK4551","BK4533","HSY","BK4532","BK4588","BK4613","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.doximity.com","stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.3326},{"period":"6month","weight":-0.2726},{"period":"1year","weight":-0.2038},{"period":"ytd","weight":-0.0111}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.0034},{"month":2,"riseRate":0.75,"avgChangeRate":0.135043},{"month":3,"riseRate":0,"avgChangeRate":-0.102936},{"month":4,"riseRate":0.25,"avgChangeRate":-0.054203},{"month":5,"riseRate":0.25,"avgChangeRate":-0.057607},{"month":6,"riseRate":0.75,"avgChangeRate":0.07265},{"month":7,"riseRate":0.8,"avgChangeRate":0.057616},{"month":8,"riseRate":0.6,"avgChangeRate":0.081551},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012183},{"month":10,"riseRate":0,"avgChangeRate":-0.088019},{"month":11,"riseRate":0.6,"avgChangeRate":0.088989},{"month":12,"riseRate":0.4,"avgChangeRate":-0.039488}],"exchange":"NYSE","name":"Doximity, Inc.","nameEN":"Doximity, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Doximity, Inc.(DOCS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Doximity, Inc.,DOCS,Doximity, Inc.股票,Doximity, Inc.股票老虎,Doximity, Inc.股票老虎国际,Doximity, Inc.行情,Doximity, Inc.股票行情,Doximity, Inc.股价,Doximity, Inc.股市,Doximity, Inc.股票价格,Doximity, Inc.股票交易,Doximity, Inc.股票购买,Doximity, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Doximity, Inc.(DOCS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Doximity, Inc.(DOCS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction